Bioorganic & Medicinal Chemistry Letters 2005-02-01

Synthesis of 2'-beta-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors.

Yili Ding, Haoyun An, Zhi Hong, Jean-Luc Girardet

文献索引：Bioorg. Med. Chem. Lett. 15(3) , 725-7, (2005)

全文：HTML全文

摘要

Coupling reaction of 2-beta-C-methyl-1,2,3,4-tetra-O-benzoyl-d-ribofuranose with 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine, followed by debromination and debenzoylation, gave the 2'-beta-C-methyl toyocamycin in high yield. Based on this result, a series of 2'-beta-C-methyl-4-substituted toyocamycin and sangivamycin analogues were synthesized for biological screening as potential inhibitors of HCV RNA replication.

相关化合物

  • NSC 65346
  • 丰加霉素

相关文献：

Synthesis and in vitro antitumor activity of some amino-deoxy 7-hexofuranosylpyrrolo[2,3-d]pyrimidines.

1998-06-01

[Carbohydr. Res. 308(3-4) , 319-28, (1998)]

Kinetics and localization of the phosphorylation of rhodopsin by protein kinase C.

1995-03-24

[J. Biol. Chem. 270(12) , 6710-7, (1995)]

Synthesis of pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. Isosteres of sangivamycin, tubercidin, and toyocamycin.

2001-03-09

[Carbohydr. Res. 331(1) , 77-82, (2001)]

Shape changes and chemokinesis of Walker carcinosarcoma cells: effects of protein kinase inhibitors (HA-1004, polymyxin B, sangivamycin and tamoxifen) and an inhibitor of diacylglycerol kinase (R 59022).

1993-01-01

[Anticancer Res. 13(2) , 347-54, (1993)]

Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9.

2012-11-01

[Mol. Cancer Ther. 11(11) , 2321-30, (2012)]

更多文献...